Your session is about to expire
← Back to Search
Sustained Release Lidocaine for Postoperative Pain
Study Summary
This trial is testing a new, slow-release formulation of the drug lidocaine for its ability to manage postoperative pain after pelvic surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is there still an opportunity to participate in this scientific investigation?
"According to the clinicaltrials.gov website, this research study is currently recruiting participants. The trial was originally announced on October 27th 2021 and has seen its last update occur on December 31st 2021."
Could you provide the details of any preceding investigations centered around ST-01?
"Currently, 214 clinical trials are researching ST-01 with 48 of those studies in their final phase. Even though the main research hub is located in Germantown, Tennessee, 1225 different locations have been recruited to take part in these trials."
What is the maximum capacity of patients taking part in this experiment?
"Affirmative. Records hosted on clinicaltrials.gov verify that this experiment, which was initially published on October 27th 2021, is currently recruiting volunteers. Approximately 120 participants have to be gathered from a single facility."
Does the Food and Drug Administration recognize ST-01 as a viable medical treatment?
"Our team has assigned ST-01 a safety rating of 2, indicating that there is evidence to support its security profile but no clinical data validating the medication's efficacy."
What ailments does ST-01 typically target?
"ST-01 is a common medical remedy for minor burns, but it may also be beneficial in treating lupus erythematosus cell, ulcerative colitis, and transplantation."
Share this study with friends
Copy Link
Messenger